SCH-1473759, identified by its CAS number 1094069-99-4, is a chemical compound that has garnered interest in pharmaceutical research, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. The compound is typically studied for its interactions with certain biological targets, which may include enzymes or receptors involved in disease processes. Its solubility, stability, and pharmacokinetic properties are also key characteristics that influence its efficacy and safety profile in potential drug development. As with many compounds in this category, detailed studies on its mechanism of action, toxicity, and therapeutic index are essential for understanding its viability as a candidate for clinical use. Overall, SCH-1473759 represents a promising area of research within medicinal chemistry, with ongoing investigations aimed at elucidating its full potential in treating specific health conditions.

SCH-1473759

1094069-99-4: SCH-1473759, identified by its CAS number 1094069-99-4, is a chemical compound that has garnered interest in pharmaceutical research, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. The compound is typically studied for its interactions with certain biological targets, which may include enzymes or receptors involved in disease processes. Its solubility, stability, and pharmacokinetic properties are also key characteristics that influence its efficacy and safety profile in potential drug development. As with many compounds in this category, detailed studies on its mechanism of action, toxicity, and therapeutic index are essential for understanding its viability as a candidate for clinical use. Overall, SCH-1473759 represents a promising area of research within medicinal chemistry, with ongoing investigations aimed at elucidating its full potential in treating specific health conditions.

<p>SCH-1473759 is a small molecule that inhibits endoreduplication and autophagy in cancer cells. It is also a specific agent for cancer therapy. Clinical studies have found that SCH-1473759 has low expression in human liver, which may be due to the methylation of its gene promoter region. This drug has been shown to inhibit tumor growth in cell culture and animal models. SCH-1473759 has not yet been approved by the FDA for use in humans as a cancer treatment. This drug targets cancer cells by inhibiting the activity of DNA methyltransferase 1 (Dnmt1). The effective dose for SCH-1473759 is unknown, but it is believed to be less than 100 mg/kg per day when administered orally.</p>

<p>SCH-1473759 is an inhibitor of the aurora (IC50s: 4 and 13 nM for Aurora A and B, respectively).</p>

CAS 1094069-99-4

SCH-1473759

SCH-1473759

Ref: IN-DA007AWZ

SCH-1473759

Ref: 3D-UTB06999

SCH-1473759

Ref: TM-T16862